We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Global Laboratory Informatics Market to Reach USD 3.16 Billion by 2022

By LabMedica International staff writers
Posted on 20 Sep 2017
Print article
The global laboratory informatics market is projected to grow at a CAGR of 6.4% from USD 2.32 billion in 2017 to USD 3.16 billion by 2022, driven by the increasing need for lab automation, development of integrated lab informatics solutions, regulatory requirements, growing demand in biobanks/biorepositories, academic research institutes, and CROs, and rising awareness.

These are the latest findings of Research and Markets (Dublin, Ireland), a global market research company.

In 2017, the LIMS segment is expected to account for the largest share of the global laboratory informatics market, based on the type of solutions offered, and is also projected to record the highest CAGR during the forecast period, due to the wide range of benefits associated with the use of these systems, including increased workflow efficiencies, easy integration with other lab systems, reduced transcription errors, and better regulatory compliance.

In 2017, the services segment is expected to account for the largest share of the global laboratory informatics market, by component, and record a high growth during the forecast period, driven by technological advancements in solution offerings by various vendors, increasing adoption of cloud-based solutions, growing need for consulting services, and the recurring nature of services.

The on-premise segment is expected to hold the largest share of the global laboratory informatics market, by deployment model, while the cloud-based segment is expected to record the highest CAGR during the forecast period, due to advantages such as on-demand self-serving analytics, absence of upfront capital investment for hardware, extreme capacity flexibility, and a pay-as-you-go pricing model.

In 2017, the life sciences segment is expected to hold the largest share of the global laboratory informatics market, by industry, led by the growing applications of molecular diagnostics, rising outsourcing by pharmaceutical industries, rising need for integrated systems, stringent regulatory guidelines to be followed by pharmaceutical laboratories, increasing number of biobanks/biorepositories due to the growing number of biobanking applications, increasing need to integrate laboratory systems, and growing awareness and availability of technologically-advanced laboratory informatics solutions.

Biobanks/biorepositories are expected to witness the highest growth in the global laboratory informatics market, by type, during the forecast period, due to the demand for high-quality specimens driving the need for automated storage, preparation, and information management to obtain accurate, reliable, and standardized data, government funding for scientific research activities, and growing collaboration between market players to offer laboratory informatics solutions to biobanks.

Related Links:
Research and Markets

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: Fingertip blood sample collection on the Babson Handwarmer (Photo courtesy of Babson Diagnostics)

Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection

Warming the hand is an effective way to facilitate blood collection from a fingertip, yet off-the-shelf solutions often do not fulfill laboratory requirements. Now, a unique hand-warming technology has... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.